Pharmacy Diabetes


Participants will:
  • Understand that excess abdominal adiposity is the key underlying cause of pre-diabetes and type 2 diabetes
  • Know the common ways to assess abdominal adiposity
  • Understand the key physiological mechanisms that cause people with abdominal adiposity to develop pre-diabetes and type 2 diabetes
  • Know how VLEDs assist with the reduction of excess adipose tissue
  • Understand who is eligible to use VLEDs
  • Know what the new regulatory requirements are for VLEDs in Australia and New Zealand
  • Understand how the current Australian/NZ marketplace measures up to those requirements